The pigment epithelial-derived factor gene loaded in PLGA nanoparticles for therapy of colon carcinoma

Oncology Reports

Volumn 24, Issue 3, 2010, Pages 661-668

  Cui, Feng Yu ^b   Song, Xiang Rong ^a   Li, Zhi Yong ^a   Li, Shuang Zhi ^a   Mu, Bo ^b   Mao, Yong Qiu ^a   Wei, Yu Quan ^a   Yang, Li ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Angiogenesis; Apoptosis; CT26s; Pigment epithelial derived factor; PLGA nanoparticles; Poly (lactic co glycolic acid); Tumor

Indexed keywords

CD31 ANTIGEN; PIGMENT EPITHELIUM DERIVED FACTOR; PLASMID VECTOR; POLYGLACTIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; COLON CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; GENE DELIVERY SYSTEM; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN UMBILICAL VEIN ENDOTHELIAL CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR VOLUME; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; DEPENDOVIRUS; ENDOTHELIAL CELLS; EYE PROTEINS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LACTIC ACID; MICE; MICE, INBRED BALB C; NANOPARTICLES; NEOVASCULARIZATION, PATHOLOGIC; NERVE GROWTH FACTORS; POLYGLYCOLIC ACID; SERPINS; TIME FACTORS; TUMOR BURDEN;

EID: 77956335756     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000905     Document Type: Article

References (37)

1. Anderson WF: Human gene therapy. Nature 392: 25-30, 1998.
2. Zhang L, Chen J, Ke Y, Mansel RE and Jiang WG: Down-regulation of PEDF expression by ribozyme transgene in endothelial and lung cancer cells and its impact on angiogenesis in vitro. Oncol Rep 14: 1615-1619, 2005.
3. Dawson DW: Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285: 245-248, 1999. (Pubitemid 29329995)
4. Yang LP, Cheng P, Peng XC, et al: Anti-tumor effect of adeno-virus-mediated gene transfer of pigment epithelium-derived factor on mouse B16-F10 melanoma. J Exp Clin Cancer Res 28: 75, 2009.
5. Abe R, Shimizu T, Yamagishi S, et al: Overexpression of pigment epithelium-derived factor decreases angiogenesis and inhibits the growth of human malignant melanoma cells in vivo. Am J Pathol 164: 1225-1232, 2004.
6. Doll JA, Stellmach VM, Bouck NP, et al: Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas. Nat Med 9: 774-780, 2003.
7. Kojiro M, Hiroki I, Daisuke N, Keisuke H, Kazuhiko N and Katsumi E: Antiangiogenic property of pigment epithelium-derived factor in hepatocellular carcinoma. Hepatology 40: 252-259, 2004.
8. Garcia M, Fernandez Garcia NI, Rivas V, et al: Inhibition of xenografted human melanoma growth and prevention of metastasis development by dual antiangiogenic/antitumor activities of pigment epithelium-derived factor. Cancer Res 64: 5632-5642, 2004.
9. Hase R, Miyamoto M, Uehara H, et al: Pigment epithelium-derived factor gene therapy inhibits human pancreatic cancer in mice. Clin Cancer Res 11: 8737-8744, 2005. (Pubitemid 43005924)
10. Guan M, Yam HF, Su B, et al: Loss of pigment epithelium derived factor expression in glioma progression. J Clin Pathol 56: 277-282, 2003.
11. Guan M, Pang CP, Yam HF, et al: Inhibition of glioma invasion by overexpression of pigment epithelium-derived factor. Cancer Gene Ther 11: 325-332, 2004.
12. Christiano R: Viral and non-viral vectors for cancer gene therapy. Anticancer Res 18: 3142-3246, 1998.
13. Abdallah B, Hassan A, Benoist C, Goula D, Behr JP and Demeneix BA: A powerful non-viral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine. Hum Gene Ther 7: 1947-1954, 1996.
14. Benns JM, Maheshwari A, Furgeson DY, Mahato RI and Kim SW: Folate-PEG-folate-graft-polyethylenimine-based gene delivery. J Drug Target 9: 123-139, 2001.
15. Fischer D, Bieber T, Li Y, Elsasser HP and Kissel T: A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res 16: 1273-1279, 1999. (Pubitemid 29393618)
16. Gosselin MA, Guo W and Lee RJ: Efficient gene transfer using reversibly crosslinked low molecular weight polyethylenimine. Bioconjug Chem 12: 989-994, 2001.
17. Song XR, Cai Z, Zheng Y, et al: Reversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGANPs. Eur J Pharm Sci 37: 300-305, 2009.
18. Hedley ML, Curley J and Urban R: Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses. Nat Med 4: 365-368, 1998. (Pubitemid 28144100)
19. Perez C, Sanchez A, Putnam D, Ting D, Langer R and Alonso MJ: Poly (lactic acid)- poly (ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA. J Control Release 75: 211-224, 2001.
20. Panyam J, Zhou WZ, Prabha S, Sahoo SK and Labhasetwar V: Rapid endolysosomal escape of poly (d,l-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J 16: 1217-1226, 2002. (Pubitemid 34815409)
21. Freytag T, Dashevsky A, Tillman L, Hardee GE and Bodmeier R: Improvement of the encapsulation efficiency of oligonucleotide-containing biodegradable microspheres. J Control Release 69: 197-207, 2000.
22. Song XR, Zhao Y, Hou SX, et al: Dual agents loaded PLGANPs: systematic study of particle size and drug entrapment efficiency. Eur J Pharm Biopharm 69: 445-453, 2008.
23. Cohen H, Levy RJ, Gao J, Fishbein I, Kousaev V and Sosnowski S: Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles. Gene Ther 7: 1896-1905, 2000.
24. Li G, Tian L, Hou JM, et al: Improved therapeutic effectiveness by combining recombinant CXC chemokine ligand 10 with Cisplatin in solid tumors. Clin Cancer Res 11: 4217-4224, 2005.
25. Wang L, Schmitz V, Perez-Mediavilla A, Izal I, Prieto J and Qian C: Suppression of angiogenesis and tumor growth by aden-viral-mediated gene transfer of pigment epithelium-derived factor. Mol Ther 8: 72-79, 2003.
26. Peng XC, Yang L, Yang LP, et al: Efficient inhibition of murine breast cancer growth and metastasis by gene transferred mouse survivin Thr34→Ala mutant. J Exp Clin Cancer Res 27: 46, 2008.
27. Weidner N, Semple JP, Welch WR and Folkman J: Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 324: 1-8, 1991.
28. Lee M, Rentz J, Bikram M, Han S, Bull DA and Kim SW: Hypoxiainducible VEGF gene delivery to ischemic myocardium using watersoluble lipopolymer. Gene Ther 10: 1535-1542, 2003. (Pubitemid 37063258)
29. Abdallah B, Hassan A, Benoist C, Goula D, Behr JP and Demeneix BA: A powerful non-viral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine. Hum Gene Ther 7: 1947-1954, 1996.
30. Kang SW, Lim HW, Seo SW, Jeon O, Lee M and Kim BS: Nanosphere-mediated delivery of vascular endothelial growth factor gene for therapeutic angiogenesis in mouse ischemic limbs. Biomaterials 29: 1109-1117, 2008.
31. Takenaka K, Yamagishi S, Jinnouchi Y, Nakamura K, Matsui T and Imaizumi T: Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cells. Life Sci 77: 3231-3241, 2005.
32. Filleur S, Volz K, Nelius T, et al: Two functional epitopes of pigment epithelial-derived factor block angiogenesis and induce differentiation in prostate cancer. Cancer Res 65: 5144-5152, 2005.
33. Gimbrone MA Jr, Leapman SB, Cotran RS and Folkman J: Tumor dormancy in vivo by prevention of neovascularization. J Exp Med 136: 261-276, 1972.
34. Folkman J: Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182-1186, 1971.
35. Abe R, Fujita Y, Yamagishi S and Shimizu H: Pigment epithelium-derived factor prevents melanoma growth via angiogenesis inhibition. Curr Pharm Des 14: 3802-3809, 2008.
36. Zhang T, Guan M, Xu C, Chen Y and Lu Y: Pigment epithelium-derived factor inhibits glioma cell growth in vitro and in vivo. Life Sci 81: 1256-1263, 2007. (Pubitemid 47539504)
37. Uehara H, Miyamoto M, Kato K, et al: Expression of pigment epithelium-derived factor decreases liver metastasis and correlates with favorable prognosis for patients with ductal pancreatic carcinoma. Cancer Res 64: 3533-3537, 2004.